Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 3Peripheral Nervous System Diseases 3Ovarian Neoplasms 3Lung Neoplasms 3Carcinoma, Hepatocellular 3Stomatitis 2Stomach Neoplasms 2Pseudomyxoma Peritonei 2Ototoxicity 2Neurofibromatosis 1 2Neoplasms 2Liver Neoplasms 2Hearing Loss 2Head and Neck Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Weight Loss 1Ulcer 1Tongue Neoplasms 1Tomaculous neuropathy 1Thrombocythemia, Essential 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Salivary Gland Neoplasms 1Renal Insufficiency, Chronic 1Renal Artery Obstruction 1Radiation-Induced Mucositis 1Radiation Pneumonitis 1Pulmonary Embolism 1Primary Myelofibrosis 1Primary Graft Dysfunction 1

Interventions

sodium thiosulfate 4Cisplatin 3Acetylcysteine 2tempol 1ebselen 1Vorinostat 1Thioctic Acid 1Sodium Chloride 1Restraint, Physical 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Pantoprazole 1Methotrexate 1Hydroxymethylglutaryl-CoA Reductase Inhibitors 1Hyaluronic Acid 1Hearing Tests 1Dexamethasone 1Chemotherapy, Adjuvant 1Audiometry 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Ototoxicity × Acetylcysteine × Clear all
NCT06297369 2024-03-07

Evaluation of the Effect of N-acetylcysteine in Preventing Cisplatin-Induced Toxicities in Cancer Patients

Ain Shams University

Phase 2 Unknown
60 enrolled

Ototoxicity, Peripheral Nervous System Diseases

NCT03400709 2018-01-17

Protective Role of N-acetylcisteine From Cisplatin-induced Ototoxicity in Patients With Head and Neck Cancer

Hospital San Juan de Dios, Santiago

Phase NA Completed
45 enrolled

Ototoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡